Company Filing History:
Years Active: 2022-2024
Title: Xiong Zhang: Innovator in Synthetic Antibacterial Compounds
Introduction
Xiong Zhang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of synthetic compounds, particularly in the development of antibacterial agents. With a total of 3 patents to his name, Zhang's work is paving the way for advancements in pharmaceutical compositions.
Latest Patents
Zhang's latest patents include innovative synthetic antibacterial compounds. These compounds are characterized by a specific structure that includes substituted or unsubstituted aromatic or heteroaromatic mono- or polycyclic ring systems. Additionally, they feature C-Calkyl or alkenyl groups, or pharmaceutically acceptable salts. These compounds and their pharmaceutical compositions are designed to inhibit the growth of bacteria effectively. Another significant patent involves processes for preparing ortho-allylated hydroxy aryl compounds. This process entails reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compounds, resulting in valuable compounds for various applications.
Career Highlights
Xiong Zhang is affiliated with McMaster University, where he continues to engage in research and development. His work focuses on creating innovative solutions to combat bacterial infections through synthetic chemistry. His contributions have been recognized within the scientific community, showcasing his expertise and dedication to advancing medical science.
Collaborations
Zhang collaborates with esteemed colleagues such as Jakob Magolan and Nicholas Jentsch. These partnerships enhance the research efforts and broaden the impact of their findings in the field of synthetic compounds.
Conclusion
Xiong Zhang's innovative work in synthetic antibacterial compounds demonstrates his commitment to improving healthcare solutions. His patents reflect a deep understanding of chemistry and its applications in medicine. Zhang's contributions are vital in the ongoing fight against bacterial infections, showcasing the importance of innovation in the pharmaceutical industry.